Cargando…

Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1-AKT/ERK-Snail signaling pathway

Cyclovirobuxine D (CVB-D) is an alkaloid, which is mainly derived from Buxus microphylla. It has been reported that CVB-D has positive effects on breast cancer, gastric cancer and other malignant tumors. However, to the best of our knowledge, there are no reports regarding the effects of CVB-D on co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Fengqi, Chen, Yaodong, Ren, Shuo, Li, Zizhuo, Sun, Kan, Xing, Yanwei, Zhu, Yuekun, Piao, Daxun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252468/ https://www.ncbi.nlm.nih.gov/pubmed/32319595 http://dx.doi.org/10.3892/ijo.2020.5038

Ejemplares similares

Fangchinoline exerts antitumour activity by suppressing the EGFR-PI3K/AKT signalling pathway in colon adenocarcinoma
por: Jiang, Fengqi, et al.
Publicado: (2021)

ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway
por: Xing, Yanwei, et al.
Publicado: (2019)

Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway
por: Liu, Yadong, et al.
Publicado: (2021)

miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2
por: Li, Hailin, et al.
Publicado: (2019)

Long noncoding RNA SNHG6 promotes the progression of colorectal cancer through sponging miR-760 and activation of FOXC1
por: Zhu, Yuekun, et al.
Publicado: (2018)

GSK-3β phosphorylation-dependent degradation of ZNF281 by β-TrCP2 suppresses colorectal cancer progression
por: Zhu, Yuekun, et al.
Publicado: (2017)

LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis
por: Ren, Niansheng, et al.
Publicado: (2020)

Cyclovirobuxine D pretreatment ameliorates septic heart injury through mitigation of ferroptosis
por: Wang, Jianxin, et al.
Publicado: (2023)

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018)

Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D
por: Ke, Zhongcheng, et al.
Publicado: (2016)

Let-7c-5p Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma
por: Zheng, Yaxin, et al.
Publicado: (2020)

Collagen Triple Helix Repeat Containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells
por: Kim, Hee Cheol, et al.
Publicado: (2014)

Let-7c-5p Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma [Retraction]
Publicado: (2023)

Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
por: Guo, Qian, et al.
Publicado: (2015)

Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
por: Jiang, Zhaohui, et al.
Publicado: (2020)

MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis
por: Zhou, Qingxin, et al.
Publicado: (2016)

Cyclovirobuxine D Inhibits Cell Proliferation and Induces Mitochondria-Mediated Apoptosis in Human Gastric Cancer Cells
por: Wu, Jie, et al.
Publicado: (2015)

The role of CTHRC1 in promotion of cutaneous wound healing
por: Duan, Xianlan, et al.
Publicado: (2022)

MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro
por: Liu, Jingtian, et al.
Publicado: (2018)

Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low-grade glioma
por: Zhou, Lingqi, et al.
Publicado: (2020)

Cyclovirobuxine D Induces Apoptosis and Mitochondrial Damage in Glioblastoma Cells Through ROS-Mediated Mitochondrial Translocation of Cofilin
por: Zhang, Lin, et al.
Publicado: (2021)

Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro
por: Gao, Ge, et al.
Publicado: (2022)

Cthrc1 Is a Positive Regulator of Osteoblastic Bone Formation
por: Kimura, Hiroaki, et al.
Publicado: (2008)

Cthrc1, a Novel Circulating Hormone Regulating Metabolism
por: Stohn, J. Patrizia, et al.
Publicado: (2012)

CTHRC1 facilitates bladder cancer cell proliferation and invasion through regulating the PI3K/Akt signaling pathway
por: Li, Yubing, et al.
Publicado: (2019)

CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma
por: Wang, Yunpeng, et al.
Publicado: (2017)

The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis
por: Mei, Dan, et al.
Publicado: (2020)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling
por: Bao, Fan, et al.
Publicado: (2023)

DNA repair pathways-targeted cyclovirobuxine inhibits castration-resistant prostate cancer growth by promoting cell apoptosis and cycle arrest
por: Gao, Ke, et al.
Publicado: (2023)

ERK/MAPK signalling pathway and tumorigenesis
por: Guo, Yan-Jun, et al.
Publicado: (2020)

Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways
por: Zhao, Jingkun, et al.
Publicado: (2017)

CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis
por: Myngbay, Askhat, et al.
Publicado: (2019)

A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma
por: Han, Songling, et al.
Publicado: (2021)

Application Potential of CTHRC1 as a Diagnostic and Prognostic Indicator for Colon Adenocarcinoma
por: Pang, Chen, et al.
Publicado: (2022)

SULF2 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells through the ERK/AKT signaling pathway
por: Jiang, Tao, et al.
Publicado: (2020)

Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
por: Huang, Zhen, et al.
Publicado: (2021)

CTHRC1 and PD-1/PD-L1 expression predicts tumor recurrence in prostate cancer
por: Zhou, Qing, et al.
Publicado: (2019)

BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling
por: Urban, Bettina C, et al.
Publicado: (2016)

PTEN suppresses tumorigenesis by directly dephosphorylating Akt
por: Bu, Lang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5jikr8ia41k0f9k3s31t0eqvna